118 related articles for article (PubMed ID: 38794790)
1. Gross morphologic features of surgical specimen in rectal cancer patients with pathological complete response following neoadjuvant chemoradiotherapy: A cross-sectional study.
Fazeli AR; Tadbir Vajargah K; Fazeli MS; Behboudi B; Ahmadi-Tafti SM; Kazemeini A; Keshvari A; Keramati MR
World J Surg; 2024 May; ():. PubMed ID: 38794790
[TBL] [Abstract][Full Text] [Related]
2. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
3. Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy.
Smith FM; Wiland H; Mace A; Pai RK; Kalady MF
Dis Colon Rectum; 2014 Mar; 57(3):311-5. PubMed ID: 24509452
[TBL] [Abstract][Full Text] [Related]
4. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
5. Tumor Volume as Predictor of Pathologic Complete Response Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
Lutsyk M; Awawda M; Gourevich K; Ben Yosef R
Am J Clin Oncol; 2021 Sep; 44(9):482-486. PubMed ID: 34269693
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance Tumor Regression Grade and Residual Mucosal Abnormality as Predictors for Pathological Complete Response in Rectal Cancer Postneoadjuvant Chemoradiotherapy.
Bhoday J; Smith F; Siddiqui MR; Balyasnikova S; Swift RI; Perez R; Habr-Gama A; Brown G
Dis Colon Rectum; 2016 Oct; 59(10):925-33. PubMed ID: 27602923
[TBL] [Abstract][Full Text] [Related]
7. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
8. The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy.
Smith FM; Chang KH; Sheahan K; Hyland J; O'Connell PR; Winter DC
Br J Surg; 2012 Jul; 99(7):993-1001. PubMed ID: 22351592
[TBL] [Abstract][Full Text] [Related]
9. Does residual microscopic disease after chemoradiotherapy for locally advanced rectal cancer translate into a good clinical outcome?
Geva R; Davidovics H; Soyfer S; Pelles-Avraham S; Klausner JM; Inbar M; Tulchinsky H
Colorectal Dis; 2017 Mar; 19(3):237-242. PubMed ID: 27474791
[TBL] [Abstract][Full Text] [Related]
10. [Predictive factors of pathological complete response after neoadjuvant chemoradiotherapy for middle-low rectal cancer].
Liu QZ; Zhang H; Hao LQ; Lou Z; Liu LJ; Gao XH; Gong HF; Hong YG; Xin C; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Dec; 23(12):1159-1163. PubMed ID: 33353270
[No Abstract] [Full Text] [Related]
11. Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.
Zeng WG; Liang JW; Wang Z; Zhang XM; Hu JJ; Hou HR; Zhou HT; Zhou ZX
Chin J Cancer; 2015 Aug; 34(10):468-74. PubMed ID: 26268466
[TBL] [Abstract][Full Text] [Related]
12. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
[TBL] [Abstract][Full Text] [Related]
13. ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.
Li Q; Luo D; Zhu J; Yang L; Liu Q; Ma Y; Liang L; Cai S; Zhang Z; Li X;
BMC Cancer; 2019 Nov; 19(1):1117. PubMed ID: 31729964
[TBL] [Abstract][Full Text] [Related]
14. Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
Zhang Q; Liang J; Chen J; Mei S; Wang Z
Asian Pac J Cancer Prev; 2021 May; 22(5):1607-1611. PubMed ID: 34048192
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of complete pathological response in patients with locally advanced rectal cancer.
Engel RM; Oliva K; Koulis C; Yap R; McMurrick PJ
Int J Colorectal Dis; 2020 Sep; 35(9):1759-1767. PubMed ID: 32474708
[TBL] [Abstract][Full Text] [Related]
16. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
[TBL] [Abstract][Full Text] [Related]
17. Local Excision Techniques for Rectal Cancer After Neoadjuvant Chemoradiotherapy: What Are We Doing?
Smith FM; Ahad A; Perez RO; Marks J; Bujko K; Heald RJ
Dis Colon Rectum; 2017 Feb; 60(2):228-239. PubMed ID: 28059920
[TBL] [Abstract][Full Text] [Related]
18. Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
Ryan JE; Warrier SK; Lynch AC; Heriot AG
Colorectal Dis; 2015 Oct; 17(10):849-61. PubMed ID: 26260213
[TBL] [Abstract][Full Text] [Related]
19. The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Daniel ES; Gibbs P; Guerrieri M; Faragher I
Colorectal Dis; 2014 Oct; 16(10):783-7. PubMed ID: 24786681
[TBL] [Abstract][Full Text] [Related]
20. [Predictive factors associated with pathologic complete response after neoadjuvant chemoradiotherapy in rectal cancer].
Sun Y; Chi P; Xu B; Lin H; Lu X; Huang Y; Xu Z; Huang S; Jiang C
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):556-60. PubMed ID: 24953361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]